News and Insights
Case Study: Developing an ECV Framework and Portfolio Risk Assessment
A global biotechnology market leader became concerned by a new level of buyer resistance its sales teams were facing. The company worked with Numerof to undertake a portfolio-wide assessment of the strength of the economic and clinical effectiveness message being delivered to key stakeholders.Read More
Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.